CFTR and cystic fibrosis: Cystic fibrosis transmembrane conductance regulator modulator (mCFTR) therapy is the first variant-specific therapy (VST) tailored to the genetic defect that has brought transformative changes in cystic fibrosis (CF) care in recent years [1].